Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.

M Gnant; M Filipits; Richard Greil; H Stoeger; M Rudas; Z Bago-Horvath; Brigitte Mlineritsch; W Kwasny; M Knauer; C Singer; R Jakesz; P Dubsky; F Fitzal; R Bartsch; G Steger; M Balic; Sigrun Ressler; J W Cowens; J Storhoff; S Ferree; C Schaper; S Liu; C Fesl; T O Nielsen

doi:10.1093/annonc/mdt494

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.

M Gnant, M Filipits, Richard Greil (Co-author), H Stoeger, M Rudas, Z Bago-Horvath, Brigitte Mlineritsch (Co-author), W Kwasny, M Knauer, C Singer, R Jakesz, P Dubsky, F Fitzal, R Bartsch, G Steger, M Balic, Sigrun Ressler (Co-author), J W Cowens, J Storhoff, S FerreeC Schaper, S Liu, C Fesl, T O Nielsen

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

293 Citations (Web of Science)

Original language	English
Pages (from-to)	339-345
Journal	ANNALS OF ONCOLOGY
Volume	25
Issue number	2
DOIs	https://doi.org/10.1093/annonc/mdt494
Publication status	Published - 2014

Keywords

TAMOXIFEN
ANASTROZOLE
CONSENSUS
SUBTYPES
WOMEN

Access to Document

10.1093/annonc/mdt494

Cite this

Gnant, M., Filipits, M., Greil, R., Stoeger, H., Rudas, M., Bago-Horvath, Z., Mlineritsch, B., Kwasny, W., Knauer, M., Singer, C., Jakesz, R., Dubsky, P., Fitzal, F., Bartsch, R., Steger, G., Balic, M., Ressler, S., Cowens, J. W., Storhoff, J., ... Nielsen, T. O. (2014). Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone. ANNALS OF ONCOLOGY , 25(2), 339-345. https://doi.org/10.1093/annonc/mdt494

Gnant, M ; Filipits, M ; Greil, Richard et al. / Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone. In: ANNALS OF ONCOLOGY 2014 ; Vol. 25, No. 2. pp. 339-345.

@article{2ae74797770043f4ba26520c6bd1bfd9,

title = "Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.",

keywords = "TAMOXIFEN, ANASTROZOLE, CONSENSUS, SUBTYPES, WOMEN",

author = "M Gnant and M Filipits and Richard Greil and H Stoeger and M Rudas and Z Bago-Horvath and Brigitte Mlineritsch and W Kwasny and M Knauer and C Singer and R Jakesz and P Dubsky and F Fitzal and R Bartsch and G Steger and M Balic and Sigrun Ressler and Cowens, {J W} and J Storhoff and S Ferree and C Schaper and S Liu and C Fesl and Nielsen, {T O}",

note = "IIIrd Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg",

year = "2014",

doi = "10.1093/annonc/mdt494",

language = "English",

volume = "25",

pages = "339--345",

journal = "ANNALS OF ONCOLOGY ",

issn = "0923-7534",

publisher = "Elsevier ",

number = "2",

}

Gnant, M, Filipits, M, Greil, R, Stoeger, H, Rudas, M, Bago-Horvath, Z, Mlineritsch, B, Kwasny, W, Knauer, M, Singer, C, Jakesz, R, Dubsky, P, Fitzal, F, Bartsch, R, Steger, G, Balic, M, Ressler, S, Cowens, JW, Storhoff, J, Ferree, S, Schaper, C, Liu, S, Fesl, C & Nielsen, TO 2014, 'Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.', ANNALS OF ONCOLOGY , vol. 25, no. 2, pp. 339-345. https://doi.org/10.1093/annonc/mdt494

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone. / Gnant, M; Filipits, M; Greil, Richard (Co-author) et al.
In: ANNALS OF ONCOLOGY , Vol. 25, No. 2, 2014, p. 339-345.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.

AU - Gnant, M

AU - Filipits, M

AU - Greil, Richard

AU - Stoeger, H

AU - Rudas, M

AU - Bago-Horvath, Z

AU - Mlineritsch, Brigitte

AU - Kwasny, W

AU - Knauer, M

AU - Singer, C

AU - Jakesz, R

AU - Dubsky, P

AU - Fitzal, F

AU - Bartsch, R

AU - Steger, G

AU - Balic, M

AU - Ressler, Sigrun

AU - Cowens, J W

AU - Storhoff, J

AU - Ferree, S

AU - Schaper, C

AU - Liu, S

AU - Fesl, C

AU - Nielsen, T O

N1 - IIIrd Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg

PY - 2014

Y1 - 2014

KW - TAMOXIFEN

KW - ANASTROZOLE

KW - CONSENSUS

KW - SUBTYPES

KW - WOMEN

U2 - 10.1093/annonc/mdt494

DO - 10.1093/annonc/mdt494

M3 - Original Article

C2 - 24347518

SN - 0923-7534

VL - 25

SP - 339

EP - 345

JO - ANNALS OF ONCOLOGY

JF - ANNALS OF ONCOLOGY

IS - 2

ER -

Gnant M, Filipits M, Greil R, Stoeger H, Rudas M, Bago-Horvath Z et al. Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone. ANNALS OF ONCOLOGY . 2014;25(2):339-345. doi: 10.1093/annonc/mdt494